| BRIACELL THERAPEUTICS NEW |
| Kanada |
| Gesundheit |
| CA1079303071 / A41DJH |
| 8BT (Frankfurt) / BCTX (NASDAQ) |
| FRA:8BT, ETR:8BT, 8BT:GR, NASDAQ:BCTX |
| - |
| https://briacell.com/ |
|
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company specializing in developing novel immunotherapies to transform cancer care. The company focuses on cell-based cancer immunotherapies designed to harness and direct the immune system..
>Volltext.. |
| 25.86 Mio. EUR |
| 0.06 Mio. EUR |
| - |
| -27.09 Mio. EUR |
| -26.21 Mio. EUR |
| -24.69 EUR |
| - |
| 25.75 Mio. EUR |
| -27.4 Mio. EUR |
| 9.39 |
| - |
| -154.56% |
| - |
| - |
| - |
| - |
| BRIACELL |
| 04.04.26 |
|